www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHWed, 13 May 2026 07:02:13 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netThu, 30 Apr 2026 12:30:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-and-medical-conferences-in-may-15648215

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor and Medical Conferences in May 30.04.2026 / 12:30 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-and-medical-conferences-in-may-15648215Tue, 28 Apr 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-m-d-m-p-h-as-chief-medical-officer-15640484 Issuer: Immunic AG / Key word(s): Personnel Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-m-d-m-p-h-as-chief-medical-officer-15640484Thu, 23 Apr 2026 14:00:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-announces-1-for-10-reverse-stock-split-15630179 Issuer: Immunic AG / Key word(s): Statement Immunic, Inc. Announces 1-for-10 Reverse Stock Split 23.04.2026 / 14:00 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-announces-1-for-10-reverse-stock-split-15630179Thu, 09 Apr 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-scientific-and-medical-conferences-in-april-15601496 Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Scientific and Medical Conferences in April 09.04.2026 / 12:30 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-scientific-and-medical-conferences-in-april-15601496Wed, 01 Apr 2026 12:30:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-regains-compliance-with-nasdaq-minimum-bid-price-requirement-15589038 Issuer: Immunic AG / Key word(s): Miscellaneous Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement 01.04.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-regains-compliance-with-nasdaq-minimum-bid-price-requirement-15589038Tue, 31 Mar 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-strengthens-its-board-of-directors-with-the-appointment-of-seasoned-biopharmaceutical-executive-jon-congleton-15586361 Issuer: Immunic AG / Key word(s): Personnel Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-strengthens-its-board-of-directors-with-the-appointment-of-seasoned-biopharmaceutical-executive-jon-congleton-15586361Tue, 10 Mar 2026 11:30:04 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-announces-grant-of-key-european-patent-protecting-relevant-dosing-regimens-for-vidofludimus-calcium-15545901 Issuer: Immunic AG / Key word(s): Patent Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium 10.03.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-announces-grant-of-key-european-patent-protecting-relevant-dosing-regimens-for-vidofludimus-calcium-15545901Tue, 03 Mar 2026 12:30:04 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-conferences-in-march-15531033 Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor Conferences in March 03.03.2026 / 12:30 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-conferences-in-march-15531033Sun, 01 Mar 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/immunic-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15525745Immunic lud am 26.02.2026 zur Finanzkonferenz und hat dort die Zahlen zum am 31.12.2025 abgelaufenen Jahresviertel präsentiert.Für das jüngste Jahresviertel wies das Unternehmen ein EPS von -0,07 USD je Aktie aus. Ein ... ]]>https://www.finanzen.net/nachricht/aktien/immunic-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15525745Thu, 26 Feb 2026 12:30:03 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-reports-year-end-2025-financial-results-and-provides-corporate-update-15518871 Issuer: Immunic AG / Key word(s): Annual Results Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update 26.02.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-reports-year-end-2025-financial-results-and-provides-corporate-update-15518871